CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow -1.4% ·
net new positions -18.2%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | -1 | 71.70M | $2.68B | +5 | −6 |
| Q1 2026 | 93 | +2 | 73.05M | $2.65B | +9 | −7 |
| Q4 2025 | 90 | 0 | 75.54M | $3.52B | n/a | n/a |
| Q3 2025 | 15 | 0 | 56.94M | $2.37B | n/a | n/a |
| Q2 2025 | 12 | 0 | 51.44M | $1.48B | +1 | −1 |
| Q1 2025 | 9 | -2 | 19.08M | $640.10M | +2 | −4 |
| Q4 2024 | 11 | -1 | 21.01M | $1.07B | n/a | −1 |
| Q3 2024 | 11 | -2 | 14.60M | $745.98M | n/a | −2 |
| Q2 2024 | 13 | n/a | 14.80M | $663.11M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.94M | +12.2% | $252.68M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 4.46M | -3.5% | $227.89M | 0.0% | ▼ Trim | 2 | SEC ↗ ×8 |
| 3 | Point72 Asset Management ✦ | 2.30M | -17.3% | $117.56M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.85M | +10.1% | $94.46M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Fisher Asset Management ✦ | 482.10K | +8.4% | $24.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Duquesne Family Office ✦ | 309.00K | 0.0% | $15.79M | 0.6% | Held | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 135.13K | +10.9% | $6.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 65.69K | +66.0% | $3.36M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Adage Capital Partners ✦ | 40.00K | -80.1% | $2.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 7.57K | +6.2% | $386,725 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 5.41K | -49.9% | $276,655 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $6.32M | was 0.0% |
| Millennium Management | $1.93M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 241 holders, 121.45M shares, $4.08B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.